Optimizing Archaeal Lipid Biosynthesis in Escherichia coli
ACS Synthetic Biology · 16.08.2024 · 13 (8) · 2470-2479
DOI: 10.1021/acssynbio.4c00235 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Synthetic Biology, online erschienen am 03.08.2024. Verfasst von Mirthe Hoekzema und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747AG Gron…. Hauptthemen laut MEDLINE: Escherichia coli. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Government Scholarship, H2020 Marie Sklodowska-Curie Actions.
Abstract (Originalsprache)
Membrane lipid chemistry is remarkably different in archaea compared with bacteria and eukaryotes. In the evolutionary context, this is also termed the lipid divide and is reflected by distinct biosynthetic pathways. Contemporary organisms have almost without exception only one type of membrane lipid. During early membrane evolution, mixed membrane stages likely occurred, and it was hypothesized that the instability of such mixtures was the driving force for the lipid divide. To examine the compatibility between archaeal and bacterial lipids, the bacterium Escherichia coli has been engineered to contain both types of lipids with varying success. Only limited production of archaeal lipid archaetidylethanolamine was achieved. Here, we substantially increased its production in E. coli by overexpression of an archaeal phosphatidylserine synthase needed for ethanolamine headgroup attachment. Furthermore, we introduced a synthetic isoprenoid utilization pathway to increase the supply of isopentenyl-diphosphate and dimethylallyl diphosphate. This improved archaeal lipid production substantially. The archaeal phospholipids also served as a substrate for the E. coli cardiolipin synthase, resulting in archaeal and novel hybrid archaeal/bacterial cardiolipin species not seen in living organisms before. Growth of the E. coli strain with the mixed membrane shows an enhanced sensitivity to the inhibitor of fatty acid biosynthesis, cerulenin, indicating a critical dependence of the engineered E. coli strain on its native phospholipids.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Nijenborgh 7, 9747AG Groningen, Netherlands.
ORCID-Profile: Arnold J M Driessen
Förderung
- Chinese Government Scholarship
- H2020 Marie Sklodowska-Curie Actions
Zitieren
APA
Hoekzema, M., Jiang, J., & Driessen, A. J. M. (2024). Optimizing Archaeal Lipid Biosynthesis in Escherichia coli. ACS Synthetic Biology, 13(8), 2470-2479. https://doi.org/10.1021/acssynbio.4c00235
Vancouver
Hoekzema M, Jiang J, Driessen AJM. Optimizing Archaeal Lipid Biosynthesis in Escherichia coli. ACS Synthetic Biology. 2024;13(8):2470-2479. doi:10.1021/acssynbio.4c00235
BibTeX
@article{Hoekzema2024,
author = {Hoekzema, Mirthe and Jiang, Jiayi and Driessen, Arnold J M},
title = {Optimizing Archaeal Lipid Biosynthesis in Escherichia coli},
journal = {ACS Synthetic Biology},
year = {2024},
volume = {13},
number = {8},
pages = {2470--2479},
doi = {10.1021/acssynbio.4c00235}
}
EUVIMED